The combined ratio trajectory shows a sharp improvement from 85.8% in 2024Q1 to a low of 80.7% in 2025Q4, followed by a rise to 91.3% in 2026Q2. This recent uptick appears driven by a higher loss ratio (65.4% vs. 51.1% in 2025Q4), likely reflecting a return to more normalized loss costs after a period of favorable prior-year reserve development. The expense ratio has remained relatively stable around 29-30%, indicating consistent cost control. Investors should monitor whether the loss ratio stabilizes near 65% or continues to climb, as social inflation pressures could push it higher.

The decomposition of ROE shows that underwriting profitability, as measured by the underwriting margin, has been the primary driver, improving from 14.2% in 2024Q1 to a peak of 19.3% in 2025Q4 before settling at 8.7% in 2026Q2. This volatility reflects the impact of catastrophe losses and reserve development. Investment income, while not explicitly shown, likely contributes meaningfully given the large float and rising rate environment. The P/B of 2.14 implies a market expectation of strong future ROE, but the recent ROE of 6.7% is below the peer average, suggesting the market may be pricing in a recovery. Investors should assess whether the underwriting margin can sustain above 10% to justify the valuation.

The expense ratio has shown remarkable stability, hovering around 29-30% for most quarters, with a notable dip to 25.9% in 2026Q2. This suggests that HIG is effectively managing its acquisition and administrative costs, likely benefiting from its proprietary small business platform and AARP affinity partnership, which lower customer acquisition costs. The slight improvement in 2026Q2 may reflect scale benefits from premium growth. Compared to peers, HIG's expense ratio appears competitive, though direct comparisons are limited. The stability of this ratio is a positive signal for underwriting profitability, as it indicates that margin expansion is not reliant on cost-cutting that could be unsustainable.

While the premium-to-surplus ratio is not directly provided, the low D/E of 0.22 and strong equity growth to $19.6B in 2026Q2 indicate a solid capital base relative to premium volume. The P/B of 2.14 is higher than CNA's 1.23 but lower than TRV's 2.59, suggesting HIG is moderately leveraged compared to peers. The conservative leverage provides flexibility for reserve strengthening if social inflation pressures materialize. Investors should monitor the premium growth rate relative to surplus growth; if premiums accelerate faster than capital, leverage could increase, potentially straining rating agency capital requirements.

HIG's valuation multiples are at a discount to Travelers (TRV) and Chubb (CB), which is consistent with its higher exposure to personal auto and legacy asbestos liabilities. However, HIG's ROE of 6.7% in 2026Q2 is significantly below TRV's 25.6% and CB's 14.5%, which may justify the lower P/B. The market appears to be pricing in a recovery in ROE, as the forward P/E of 11.13 is only slightly higher than the trailing P/E, suggesting expectations of stable earnings. The discount to TRV may also reflect the market's skepticism about the sustainability of HIG's underwriting margins, given the recent combined ratio volatility. Investors should compare HIG's combined ratio and ROE trajectory to peers to assess whether the discount narrows or widens.